AnswersPublished14 sources
Anthropic’s Potential IPO: The Facts Behind the $2 Trillion Talk
Anthropic confirmed a confidential U.S. IPO filing on June 1, 2026, but no public S 1, price range, share count, or final listing terms had been disclosed by September 17.
Published byEdited with GPT-5.6 TerraImages generated with GPT Image 2
Research answer
Key takeaways
- Anthropic confirmed a confidential U.S. IPO filing on June 1, 2026, but no public S 1, price range, share count, or final listing terms had been disclosed by September 17.
- At a $2 trillion equity value and a reported $65 billion annualized revenue run rate, Anthropic would trade at roughly 31 times run rate revenue—before investors can assess audited results, losses, dilution, or comput...
- Hyperliquid perpetual contracts briefly implied a valuation around $2.36 trillion and later traded near $2.15 trillion, but they are synthetic derivatives rather than Anthropic shares.
AI Prompt
openai.comCreate a landscape editorial hero image for this Studio Global article: What is known about Anthropic’s potential IPO as of September 17, 2026—including its reported confidential June 1 SEC filing and planned Nas. Article summary: As of September 17, Anthropic had confirmed a confidential U.S. IPO filing, but neither an S-1 nor definitive deal terms were public. A Nasdaq IPO at roughly a $2 trillion valuation was widely reported, yet it remained a. Topic tags: general, general web, news, user generated. Style: premium digital editorial illustration, source-backed research mood, clean composition, high detail, modern web publication hero. Use reference image context only for broad subject, composition, and topical grounding; do not copy the exact image. Avoid: logos, brand marks, copyrighted characters, real person likenesses, fake screenshots, UI text, readable text, watermarks, charts w
Anthropic has taken a formal step toward going public, but the most eye-catching numbers surrounding a possible IPO still require careful interpretation. The company said it confidentially submitted a draft S-1 registration statement for a U.S. initial public offering on June 1, 2026; it did not disclose the offering’s size or terms.
Reports and pre-IPO derivatives markets have fueled discussion of a Nasdaq debut valued at about $2 trillion. That figure may signal intense investor interest in Anthropic’s growth, but it is not the same as a company-set offer price, a public-market valuation, or an approved SEC prospectus.
What Anthropic has confirmed
Anthropic confirmed the confidential draft S-1 submission, which starts a private SEC review process. A confidential filing is not a completed IPO: until a registration statement becomes public, investors do not have the prospectus materials normally used to evaluate the business. In particular, no public filing had established the number of shares, price range, final exchange, timing, or use of proceeds.
The clearest confirmed valuation benchmark is Anthropic’s May 2026 Series H financing. The company raised $65 billion at a $965 billion post-money valuation. 18
The reported $2 trillion Nasdaq scenario
Reporting around the potential offering has pointed to a Nasdaq listing, with Goldman Sachs, JPMorgan, and Morgan Stanley reportedly involved in leading a deal expected to raise more than $60 billion. Those details were reported rather than set out in a public prospectus, so they should be treated as provisional.
A $2 trillion valuation would be a little more than twice Anthropic’s $965 billion Series H valuation. Whether an eventual transaction could rank among the largest IPOs in history would depend on the actual amount sold to public investors—not simply the company’s headline market capitalization. Primary shares, secondary sales, the offer price, and the final share count all matter.
Why the revenue figure matters—and why it is incomplete
Reuters reported that Anthropic’s annualized revenue run rate exceeded $65 billion by the end of July 2026, up from roughly $47 billion in May and about $9 billion at the end of 2025. A revenue run rate extrapolates current sales; it is not the same measure as audited annual revenue. 17
Using that reported $65 billion run rate, a $2 trillion valuation implies:
- $2 trillion ÷ $65 billion = about 30.8 times revenue
- Rounded, that is roughly 31× annualized revenue
That calculation is useful as a valuation shorthand, not a verdict on value. It does not account for margins, operating costs, cash burn, stock-based compensation, dilution, customer concentration, contractual compute obligations, or future growth. Those are precisely the details a public S-1 would help investors assess.
What Hyperliquid’s $2 trillion-plus pricing actually represents
Pre-IPO perpetual-futures contracts tied to Anthropic’s valuation traded on Hyperliquid at levels implying a market capitalization above $2 trillion. Reports said the implied value peaked around $2.36 trillion before trading near $2.15 trillion on September 17. 4
These instruments should not be confused with Anthropic stock. Perpetual futures are derivatives without a fixed expiry, and venues can offer them without holding the underlying shares. 10 Their prices can reflect trader positioning, liquidity, funding dynamics, and expectations about an eventual listing.
In other words, a perp-implied valuation is evidence of speculative market sentiment—not a verified equity valuation or proof that public investors will value Anthropic at the same level.
The diligence questions a public S-1 could answer
Before treating any IPO valuation as fundamental, investors would need the disclosures absent from a confidential filing, including:
- Audited financial statements and recognized revenue
- Share count, options, restricted stock, and dilution
- Governance and voting rights
- Major customers and concentration risk
- Cloud, chip, and long-term compute commitments
- Litigation, regulatory, and AI-safety risk disclosures
- The intended use of IPO proceeds
Until then, the $965 billion Series H valuation is the most concrete disclosed financing benchmark, while the $2 trillion discussion remains reported target-setting and derivatives-market speculation. 18
4
The IPO arrives amid an AI-safety debate
Anthropic CEO Dario Amodei has also called for AI companies to slow the pace at which they improve frontier-model capabilities, arguing that the industry needs more time to manage misuse risks. His framework included independent evaluators, common safety standards among frontier labs, and international coordination.
OpenAI CEO Sam Altman publicly supported more safety evaluation work and said an OpenAI IPO in 2026 would be "ill-advised." President Donald Trump rejected the proposed slowdown, arguing that the United States should preserve its AI lead over China. China’s state-backed Global Times described Amodei’s proposal as a "Cold War" tactic aimed at China.
That political backdrop adds another layer of uncertainty to any future public offering. Anthropic’s eventual S-1 would be the key document for separating the company’s operating reality, risks, and capital needs from the expectations embedded in private-market reports and synthetic trading markets.
Studio Global AI
Continue your research
This page includes a source-backed answer you can continue inside Studio Global.
People also ask
What is the short answer to "Anthropic’s Potential IPO: The Facts Behind the $2 Trillion Talk"?
Anthropic confirmed a confidential U.S. IPO filing on June 1, 2026, but no public S 1, price range, share count, or final listing terms had been disclosed by September 17.
What are the key points to validate first?
Anthropic confirmed a confidential U.S. IPO filing on June 1, 2026, but no public S 1, price range, share count, or final listing terms had been disclosed by September 17. At a $2 trillion equity value and a reported $65 billion annualized revenue run rate, Anthropic would trade at roughly 31 times run rate revenue—before investors can assess audited results, losses, dilution, or comput...
What should I do next in practice?
Hyperliquid perpetual contracts briefly implied a valuation around $2.36 trillion and later traded near $2.15 trillion, but they are synthetic derivatives rather than Anthropic shares.